The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106.
 
Cynthia X. Ma
Consulting or Advisory Role - Agendia; AstraZeneca; Lilly; Myriad Genetics; Novartis; Pfizer; Seagen; Tempus
Research Funding - Eisai (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - Agendia; Lilly; Pfizer
 
Vera J. Suman
No Relationships to Disclose
 
A. Marilyn Leitch
No Relationships to Disclose
 
Souzan Sanati
No Relationships to Disclose
 
Kiran R. Vij
No Relationships to Disclose
 
Gary Walter Unzeitig
No Relationships to Disclose
 
Jeremy Hoog
No Relationships to Disclose
 
Mark Watson
No Relationships to Disclose
 
Olwen Mary Hahn
Leadership - Via Oncology
Stock and Other Ownership Interests - Teleflex Medical; Teleflex Medical
Honoraria - Cardinal Health (I)
Consulting or Advisory Role - Pfizer; Pfizer
Travel, Accommodations, Expenses - Cardinal Health (I)
 
J. Michael Guenther
Speakers' Bureau - Castle Biosciences
 
Abigail Suzanne Caudle
Consulting or Advisory Role - MD Anderson Physician’s Network
Research Funding - EndoMag (Inst)
Travel, Accommodations, Expenses - Endomagnetics; Endomagnetics
 
Travis Dockter
No Relationships to Disclose
 
Larissa A. Korde
No Relationships to Disclose
 
Anna Weiss
Research Funding - Myriad Genetics
 
Kelly Hunt
Consulting or Advisory Role - Armada Health Care; Merck
Research Funding - Endomagnetics (Inst); Lumicell (Inst); OncoNano Inc (Inst)
 
Clifford A. Hudis
(OPTIONAL) Uncompensated Relationships - Alliance Foundation Trials; Columbia University; Memorial Sloan-Kettering Cancer Center
 
Eric P. Winer
Stock and Other Ownership Interests - Verastem
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - Carrick Therapeutics; G1 Therapeutics; Genomic Health; GlaxoSmithKline; Jounce Therapeutics; Leap Therapeutics; Lilly; Seagen
Research Funding - Genentech (Inst); Novartis (Inst)
 
Ann H. Partridge
Patents, Royalties, Other Intellectual Property - I receive small royalty payments for co-authoring the breast cancer survivorship section of UpToDate
Travel, Accommodations, Expenses - Novartis
 
Lisa A. Carey
Research Funding - Immunomedics (Inst); Innocrin Pharma (Inst); Novartis (Inst); Syndax (Inst)
Patents, Royalties, Other Intellectual Property - Royalty-sharing agreement, investorship interest in licensed IP to startup company, Falcon Therapeutics, that is designing neural stem cell-based therapy for glioblastoma multiforme. (I)
(OPTIONAL) Uncompensated Relationships - G1 Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Sanofi (Inst)
 
Matthew James Ellis
Employment - Bioclassifier
Leadership - Bioclassifier
Stock and Other Ownership Interests - Bioclassifier
Consulting or Advisory Role - Abbvie/Stemcentrx; AstraZeneca; Celgene; Foundation Medicine; G1 Therapeutics; NanoString Technologies; Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - Patent on PAM50, which generates royalties on the license to Bioclassifier/Prosigna/Nanostring
Travel, Accommodations, Expenses - AstraZeneca; Pfizer